Nystatin - CAS 1400-61-9
Catalog number:
1400-61-9
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C47H75NO17
Molecular Weight:
926.09
COA:
Inquire
Targets:
Antifungal
Description:
Nystatin, which belongs to the polyene group of antimycotics, is frequently used as a topical agent in the treatment of oro-pharyngeal candidosis.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Fungicidin
MSDS:
Inquire
1. COMBINATION OF PIPEMIDIC ACID, COLISTIN SODIUM METHANESULFONATE AND NYSTATIN MAY BE LESS EFFECTIVE THAN NYSTATIN ALONE FOR PREVENTION OF INFECTION DURING CHEMOTHERAPY-INDUCED GRANULOCYTOPENIA IN ACUTE LEUKEMIA
KAZUMI SAMPI,* MASAHARU SAKURAI. Med. Oncol. & Tumor Pharmacother. Vol. 6, No. 4,pp. 291-296, 1989
Despite intensive infection prevention programs, the clinical course of patients with granulocytopenia continues to be complicated by fever and infection. The infections are most often caused by bacteria, especially aerobic gram-negative bacilli, normally dwelling in the alimentary tract; anaerobic bacteria rarely cause infections in the immunocompromised leukemic patients. Decontamination of the alimentary tract with agents that are selectively directed against aerobic gramnegative bacilli and do not affect the anaerobic flora, therefore, may prevent infections in these patients. Several studies have shown the efficacy of trimethoprim-sulfamethoxazole, gentamicin, nalidixic acid and colistin for the prevention of infections Abbreviations used in this paper: PPA, pipemidic acid; CLM, colistin sodium methanesulfonate; NYS, nystatin; ara-C, cytarabine; HDARA-C, high dose ara-C; DNR, daunorubicin; DHAD, mitoxantrone; ACR, aclarubicin; ANLL, acute nonlymphocytic leukemia; ALL, acute lymphocytic leukemia; GVN, gentamicin, vancomycin and nystatin.
2. Nystatin prophylaxis: efficient in high-risk nonimmuno- compromised ICU patients?
Philippe Vignon, Sandrine Normand. Intensive Care Med (2006) 32:935
Adequate selection of the eligible study population is challenging since these high-risk patients are difficult to identify, and the primary end-poin of prophylaxis should be carefully determined. Since the prevalence of candidemia and severe fungal infections in ICU patients approximates 1% and 2%, respectively, a large sample size would be required to demonstrate the efficacy of antifungal prophylaxis to reduce these rates. Such trial would therefore be impractical to conduct from both economic and clinical points of view and, more importantly, would not be clinically relevant. In addition, far more patients become colonized than infected during the ICU stay, and colonization by Candida spp. Constitutes an independent risk factor for invasive candidiasis. Finally, preemptive antifungal therapy has been recently proposed in heavily colonized, nonimmunocompromised ICU patients with well established risk factors for invasive candidiasis when their general condition abruptly deteriorates. In this subset of unstable, critically ill patients, the risk of invasive candidiasis is so high that the potential benefit of immediate antifungal treatment initiated before culture results outweighs its potential side effects. Such therapeutic strategy has recently been shown to be cost-effective in a highly selected target population that may represent approx. 7% of all ICU patients. Accordingly, we believe that future trials aimed at evaluating the usefulness of nystatin prophylaxis should include the use of preemptive therapy with predefined indications as a relevant end-point in double-blind placebo-controlled studies. We hypothesize that early nystatin prophylaxis administered in nonimmunocompromised ventilated ICU patients at high risk of invasive candidiasis would reduce the progression of colonization by Candida spp.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Antifungal Products


CAS 53370-90-4 Exalamide

Exalamide
(CAS: 53370-90-4)

Exalamide is a derivative of salicylamide used as an antifungal.

CAS 91161-71-6 Terbinafine HCl

Terbinafine HCl
(CAS: 91161-71-6)

Terbinafine HCl inhibits squalene epoxidase, preventing biosynthesis of ergosterol.

CAS 68890-66-4 Piroctone olamine

Piroctone olamine
(CAS: 68890-66-4)

Piroctone olamine, a pyridine derivate, is an anti-dandruff agent with fungicidal effect used in shampoo formulations.

CAS 23593-75-1 Clotrimazole

Clotrimazole
(CAS: 23593-75-1)

Clotrimazole is a synthetic, antifungal and broad-spectrum derivate of imidazole. It is an antifungal medication commonly used in the treatment of fungal infect...

CAS 38083-17-9 Climbazole

Climbazole
(CAS: 38083-17-9)

Climbazole is a topical antifungal agent commonly used in the treatment of human fungal skin infections such as dandruff and eczema. Climbazole has shown a high...

CAS 136212-91-4 Dermaseptin

Dermaseptin
(CAS: 136212-91-4)

Dermaseptin is a 34-residue antimicrobial peptide.

GP(33-41)

GP(33-41), a 9-aa-long peptide, is the optimal sequence of the GP1 epitope of lymphocytic choriomeningitis virus.

CAS 65277-42-1 Ketoconazole

Ketoconazole
(CAS: 65277-42-1)

Ketoconazole inhibits cyclosporine oxidase and testosterone 6 beta-hydroxylase with IC50 of 0.19 mM and 0.22 mM, respectively. It is used primarily to treat fun...

CAS 29342-05-0 Ciclopirox

Ciclopirox
(CAS: 29342-05-0)

Ciclopirox olamine (used in preparations called Batrafen, Loprox, Rejuvenail, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermato...

CAS 298708-79-9 BAY41-4109 racemic

BAY41-4109 racemic
(CAS: 298708-79-9)

BAY41-4109 racemic, a mixture of R-isomer of BAY41-4109 and S-isomer of BAY41-4109, is an antiviral compound that inhibits HBV replication by destabilizing caps...

CAS 187164-19-8 Luliconazole

Luliconazole
(CAS: 187164-19-8)

Luliconazole is an azole antifungal indicated for the topical treatment of interdigital tinea pedis.

CAS 911208-73-6 Tenofovir exalidex

Tenofovir exalidex
(CAS: 911208-73-6)

Tenofovir exalidex, also known as HDP-Tenofovir and CMX-157, is a highly potent prodrug of the antiviral tenofovir, appeared safe and well-tolerated in patients...

CAS 350-12-9 Sulbentine

Sulbentine
(CAS: 350-12-9)

Sulbentine is an antifungal.

CAS 99592-39-9 Sertaconazole nitrate

Sertaconazole nitrate
(CAS: 99592-39-9)

Sertaconazole nitrate is a topical broad-spectrum antifungal that is developed to provide an additional agent for the treatment of superficial cutaneous and muc...

CAS 141-94-6 Hexetidine

Hexetidine
(CAS: 141-94-6)

Hexetidine, mixture of stereoisomers, is an antibacterial and antifungal agent that destroy fungi by suppressing their ability to grow or reproduce.

CAS 131436-22-1 Cercosporamide

Cercosporamide
(CAS: 131436-22-1)

Cercosporamide, a natural antifungal phytotoxin, has been found to be a selective Mnk inhibitor and shows probable antileukemic effects.

CAS 135575-42-7 Pneumocandin B0

Pneumocandin B0
(CAS: 135575-42-7)

Pneumocandin B0, also called as L 688786, is an inhibitor of ß-(1,3)-D-glucan (a component of fungal cell walls) synthesis with an antifungal effect (IC50s = 70...

CAS 182760-06-1 Ravuconazole

Ravuconazole
(CAS: 182760-06-1)

Ravuconazole, also known as BMS-207147 or ER-30346, is a potent, broad spectrum and broad spectrum triazoleantifungle agent and an ergosterol biosynthesis inhib...

CAS 16732-09-5 2,4,6-Tribromophenyl caproate

2,4,6-Tribromophenyl caproate
(CAS: 16732-09-5)

2,4,6-Tribromophenyl caproate is an anti-fungal agent.

CAS 1397-89-3 Amphotericin B

Amphotericin B
(CAS: 1397-89-3)

Amphotericin B is a polyene, antifungal antibiotic produced from a strain of Streptomyces nodosus. (IC50=0.028–0.290 μg/ml)

Chemical Structure

CAS 1400-61-9 Nystatin

Quick Inquiry

Verification code

Featured Items